ENXTPA:BAIN
ENXTPA:BAINHospitality

Is There Room for Growth in Monte-Carlo SBM After a 7% Share Price Rise in 2025?

If you are weighing your options on Société Anonyme des Bains de Mer et du Cercle des Étrangers à Monaco, you are not alone. There is a lot to consider with this unique stock, especially for those looking at its place within Monaco's luxury and hospitality sector. The share price has been quietly on the move, with a 1.9% gain over the past week and 4.3% over the last month. Zoom out, and you will see a year-to-date climb of 7.4%, which stands in sharp contrast to the small dip of -1.8% over...
ENXTPA:ITP
ENXTPA:ITPPersonal Products

Assessing Interparfums After Recent Share Slide and Valuation Model Insights

If you are scratching your head over what to do with Interparfums right now, you are certainly not alone. It is a name that has managed to stir up conversation among investors, both for its resilience and its rollercoaster stock performance. Over the past year, shares have slid by 18.0 % and are down 19.9 % since the start of the year. That may raise eyebrows, especially when you factor in a five-year return of nearly 30 %. So, what is driving these moves? Some of the recent turbulence seems...
ENXTPA:BIM
ENXTPA:BIMMedical Equipment

Is bioMérieux Still Worth Watching After Recent 8.6% Dip in 2025?

So, you are considering what’s next for bioMérieux stock and wondering if this is the right moment to act. Maybe you have watched the prices ebb and flow lately, or maybe you are just tuning in. Either way, you are not alone, as investors everywhere are weighing the signals and asking if now is a smart entry, a time to hold, or a reason to steer clear. The stock’s journey has been, to put it mildly, eventful. In the past week, prices slipped by 2.7%, and over the last month, they have dropped...
ENXTPA:GET
ENXTPA:GETInfrastructure

How Does Getlink Stack Up After Recent Cross-Channel Transport Agreement?

If you’re wrestling with what to do next on Getlink, you’re not alone. The company’s share price has certainly kept investors on their toes lately. Over the last week, the stock edged up by 1.2%, hinting at fresh optimism. Zoom out a bit further, and the picture gets choppier. A dip of nearly 6% in the past month was followed by a modest 1.6% gain year-to-date, and, for the long-haulers, a 47.3% return over five years. These figures reflect both the volatility and potential that come with...
ENXTPA:RNO
ENXTPA:RNOAuto

Is Renault’s Leadership Overhaul and New Clio Launch Shaping a New Growth Story for ENXTPA:RNO?

Renault recently held the world premiere of the new Renault Clio and announced an extensive leadership restructuring, with Fabrice Cambolive taking on the new Chief Growth Officer role and Katrin Adt appointed as CEO of Dacia. This combination of a major product launch and a unified, growth-focused executive team marks a pivotal phase for Renault's brand renewal and global strategy. We'll explore how the new Renault Clio's debut and leadership changes may reshape Renault's outlook for growth...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

Exail Technologies (ENXTPA:EXA) Reports 47% Price Increase Over The Last Quarter

Exail Technologies (ENXTPA:EXA) recently achieved a significant milestone with the first sale of its DriX H-9 autonomous surface drone to a global hydrographic authority for naval defense, enhancing its foothold in the USV market. This came alongside a major European navy's order for five DriX H-8 drones. These developments, along with the confirmed expectation of double-digit revenue growth for 2025, likely bolstered market sentiment, aligning with the overall market's strong performance and...
ENXTPA:NRO
ENXTPA:NROIT

Neurones (ENXTPA:NRO) Half-Year Sales Surpass €424M But Net Income Declines

Neurones (ENXTPA:NRO) reported its half-year earnings, showing an increase in sales to EUR 424 million but a decline in net income to EUR 23 million. Despite these mixed results, the company's share price rose 3.8% last week. This movement coincides with broader market trends, as major stock indexes, including the Dow Jones and S&P 500, experienced record highs amid anticipation of interest rate cuts by the Federal Reserve. While the sales growth from Neurones supports the broader positive...